140 related articles for article (PubMed ID: 34726263)
1. A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence.
Schreuder K; Hollestein L; Nijsten TEC; Wakkee M; Louwman MWJ
Br J Dermatol; 2022 Mar; 186(3):476-484. PubMed ID: 34726263
[TBL] [Abstract][Full Text] [Related]
2. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions.
de Vries E; Micallef R; Brewster DH; Gibbs JH; Flohil SC; Saksela O; Sankila R; Forrest AD; Trakatelli M; Coebergh JW; Proby CM;
Arch Dermatol; 2012 Mar; 148(3):347-54. PubMed ID: 22431775
[TBL] [Abstract][Full Text] [Related]
3. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.
Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
Br J Dermatol; 2011 Oct; 165(4):874-81. PubMed ID: 21711333
[TBL] [Abstract][Full Text] [Related]
4. [Basal cell carcinoma: often more than one].
Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
Ned Tijdschr Geneeskd; 2011; 155(47):A4110. PubMed ID: 22129810
[TBL] [Abstract][Full Text] [Related]
5. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands.
van Hattem S; Aarts MJ; Louwman WJ; Neumann HA; Coebergh JW; Looman CW; Nijsten T; de Vries E
Br J Dermatol; 2009 Oct; 161(4):840-5. PubMed ID: 19438849
[TBL] [Abstract][Full Text] [Related]
6. The Burden of Multiple Basal Cell Carcinomas: A Population-wide Study.
Kappelin J; Ahnlide I; Ingvar Å; Nielsen K
Acta Derm Venereol; 2024 May; 104():adv40112. PubMed ID: 38803206
[TBL] [Abstract][Full Text] [Related]
7. Frequency of non-histologically diagnosed basal cell carcinomas in daily Dutch practice.
Flohil SC; van Tiel S; Koljenović S; Jaanen-van der Sanden G; Overbeek LI; de Vries E; Nijsten T
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):907-11. PubMed ID: 22211725
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
9. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands.
Pleunis N; Schuurman MS; Van Rossum MM; Bulten J; Massuger LF; De Hullu JA; Van der Aa MA
Gynecol Oncol; 2016 Sep; 142(3):440-5. PubMed ID: 27126004
[TBL] [Abstract][Full Text] [Related]
10. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
11. Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study.
Flohil SC; Seubring I; van Rossum MM; Coebergh JW; de Vries E; Nijsten T
J Invest Dermatol; 2013 Apr; 133(4):913-8. PubMed ID: 23190883
[TBL] [Abstract][Full Text] [Related]
12. Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
van Rossum MM; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof PC; Kiemeney LA; Hoogerbrugge N
Arch Dermatol Res; 2009 Apr; 301(4):295-9. PubMed ID: 18985366
[TBL] [Abstract][Full Text] [Related]
13. Incidence and trends of basal cell carcinoma in Sweden: a population-based registry study.
Kappelin J; Green AC; Ingvar Å; Ahnlide I; Nielsen K
Br J Dermatol; 2022 Jun; 186(6):963-969. PubMed ID: 34939666
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.
Venables ZC; Nijsten T; Wong KF; Autier P; Broggio J; Deas A; Harwood CA; Hollestein LM; Langan SM; Morgan E; Proby CM; Rashbass J; Leigh IM
Br J Dermatol; 2019 Sep; 181(3):474-482. PubMed ID: 30864158
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of metachronous basal cell carcinomas: a prognostic model.
Smedinga H; Verkouteren JAC; Steyerberg EW; Hofman A; Nijsten T; Vergouwe Y
Br J Dermatol; 2017 Oct; 177(4):1113-1121. PubMed ID: 28664573
[TBL] [Abstract][Full Text] [Related]
16. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands.
Flohil SC; de Vries E; Neumann HA; Coebergh JW; Nijsten T
Acta Derm Venereol; 2011 Jan; 91(1):24-30. PubMed ID: 21264452
[TBL] [Abstract][Full Text] [Related]
17. Predictions of skin cancer incidence in the Netherlands up to 2015.
de Vries E; van de Poll-Franse LV; Louwman WJ; de Gruijl FR; Coebergh JW
Br J Dermatol; 2005 Mar; 152(3):481-8. PubMed ID: 15787817
[TBL] [Abstract][Full Text] [Related]
18. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
19. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women.
Birch-Johansen F; Jensen A; Mortensen L; Olesen AB; Kjær SK
Int J Cancer; 2010 Nov; 127(9):2190-8. PubMed ID: 20473901
[TBL] [Abstract][Full Text] [Related]
20. The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays.
Slotman E; Schreuder K; Nijsten TEC; Wakkee M; Hollestein L; Mooyaart A; Siesling S; Louwman MWJ
J Eur Acad Dermatol Venereol; 2022 May; 36(5):680-687. PubMed ID: 35092107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
